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(RILD). RILD is typically described as consisting of an early phase of 
transient radiation pneumonitis and a late phase of persistent fibrosis. 
Previous studies have documented a local increase in radiological 
density as a function of the locally delivered dose. However, in these 
investigations only NSCLC patients receiving simple non-IMRT 
techniques were considered and little response has typically been 
observed in the low dose regions (5-10 Gy). The present study 
investigates time-dependent dose-response relationships of healthy 
lung tissue for NSCLC patients treated by IMRT. 
Materials and Methods: The study comprises 132 NSCLC patients 
treated with IMRT delivered as static field step-and-shoot or VMAT 
between October 2007 to August 2012 to a prescribed dose of 60 or 66 
Gy in 2 Gy fractions. Each patient had a series of follow-up CT scans 
which were co-registered (Elastix) to the planning CT scan using 
deformable registration. Follow-up scans were excluded from the 
study after clinical or radiological evidence of local recurrence or 
development of metastases in the thoracic region, leaving 390 
successful registrations eligible for further analysis. 3D maps of lung 
density changes were created by a voxel-by-voxel subtraction of the 
planning CT from the co-registered follow-up CT. The planned dose 
distribution was correlated to the map of density changes within the 
healthy lung tissue. The population average response was investigated 
by binning the individual dose-response curves in time intervals after 
the commencement of radiotherapy. 
Results: The figure shows the population average dose response at 
different time intervals after radiotherapy. Within the first 3 months, 
a significant increase in lung density was observed for all dose 
intervals (P<0.0001). In this time interval the density change from 
baseline increases as function of dose and reaches a plateau around 
45 Gy. At later intervals the response function changed appearance. 
The response in regions receiving 5-45 Gy decreased compared to 3 
months (P=0.014), while the plateau was replaced by a peak at high 
doses. At 6 months, regions receiving 55-60 Gy exhibited an increase 
inresponse compared to 3 months (P=0.013). After 6 months, regions 
receiving 45-60 Gy also displayed a decreased response (P=0.026). 
After 15 months the response stabilized at all dose intervals. 
Conclusions: NSCLC patients treated by modern radiotherapy 
techniques exhibit a significant increase in density of healthy lung 
tissue even at low dose levels (5-10 Gy). The transient nature of the 
response is indicative of radiation pneumonitis, while the eventual 
stabilization of the response likely is associated with fibrosis. The 
temporal evolution of the response differs in the high- and low-dose 
region. This finding suggests distinct dose-dependent time 
characteristics for the development of radiation pneumonitis and 
fibrosis. 
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Purpose/Objective: The use of parotid gland (PG) sparing intensity-
modulated radiotherapy (IMRT) significantly reduces high grade 
xerostomia. Water alone is a poor oral mucosal lubricant; the 
inorganic and organic salivary components are suggested to increase 
moisture retention on the mucosa. PG saliva comprises ~70% and 30% 
of stimulated and unstimulated saliva volume respectively. Despite 
the use of PG sparing IMRT, rates of high grade xerostomia are ~35% at 
1 year. Data on saliva composition analysis post radiotherapy (RT) is 
limited pre-IMRT due to poor residual salivary flow. We present an 
analysis of PG saliva flow rate and composition for patients treated 
with IMRT within four trials at The RMH. 
Materials and Methods: Samples were collected in the PARSPORT trial 
(CRUK/003/005) and 3 single institution, phase 2 studies (Midline (CCR 
2588), Dose Escalation (CCR1978) and Nasopharynx (CCR 2608)). 
Stimulated and unstimulated PG salivas were collected from right and 
left glands using Lashley cups (2% citric acid). Collect was at baseline 
(BL), 3, 6, 12 and 24 months(m) post-IMRT. Samples were suitable for 
analysis if a pre-IMRT and chemotherapy (BL) and ≥1 subsequent 
sample, of adequate volume (>150µl) were collected. Salivas were 
analysed for protein and ionic components using ELISA (IgA, B2M and 
lactoferrin), BCA assay (total protein) and ICP-mass spectrometry 
(Ca2+, Na+). Flow rates were determined gravitometrically (1g=1ml). 
Samples were statistically analysed for early (3-6m post-IMRT) and 
late (12-24m post-IMRT) changes using wilcoxon signed rank or paired 
t-tests and reported as % change from BL. 
Results: Twenty-one patients provided 120 samples for analysis. 
Seventeen patients were male, mean patient age was 58.4 yr and 14 
received chemotherapy. Mean PG RT dose was 27.8Gy. Sequential 
results (table 1) showed significant changes in several parameters a 
persistent (early and late) increase in lactoferrin. An early increase in 
B2M and Na+ concentration and an early decrease in PG saliva flow 
rate. Both resolved to normal after 12m. Stimulated calcium 
concentration (Ca2+) was persistently decreased by ~20%. All other 
parameters were not significantly altered. 
 
 
% of BL (100%), Median 
(IQR) 
Unstimulated PG Saliva 
(*=p<0.05) 
% of BL (100%), Median 
(IQR) 
Stimulated PG saliva 
(*=p<0.05) 
Parameter 3-6m (n=24) 
12-24m 
(n=12) 
3-6m 
(n=17) 
12-24m 
(n=12 
Total Protein 
Concentration n.s. n.s. n.s. n.s.  
Total Protein 
Secretion Rate 
38.0%* 
(10.7-
101.0) 
n.s. n.s. n.s.  
PG Saliva Flow 
Rate 
39.3%* 
(25.0-
120.8) 
n.s. 45.1%* (21.0-99.2) n.s.  
IgA 
Concentration n.s. n.s. n.s. n.s.  
B2M 
Concentration 
130.4%* 
(77.6-
200.9) 
n.s. 
125.2%* 
(98.4-
224.3) 
n.s. 
LF Concentration 
289.5%* 
(119.7-
626.7) 
386.9%* 
(574.4-
641.6) 
279.1%* 
(165.6-
583.5) 
225.5%* 
(89.4-
317.6) 
Ca2+ 
Concentration n.s. n.s. 
77.7%* 
(63.9-
83.7) 
80.5%* 
(73.1-
107.2) 
Na+ 
Concentration n.s. n.s. 
126.2%* 
(114.3-
345.2) 
n.s. 
 
Conclusions: An elevated Na+ concentration suggests transient ductal 
dysfunction. Salivary flow rates returned to baseline after 12 months 
indicating good functional recovery post IMRT. Persistently reduced 
Ca2+ concentration may affect mucin-mucin interactions and mucin 
retention with water on the buccal mucosa. This may also have a 
negative impact on long-term dental remineralisation. 
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Purpose/Objective: Since December 2011, we planned adjuvant 
radiotherapy for breast cancer with fixed angle Intensity Modulated 
Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy 
